We are live on ! Find out more
LMR Partners

LMR Partners Portfolio holdings

AUM $32.6B Turnover 45.82%
1-Year Est. Return 45.61%
 

LMR Partners is a British multi-strategy investment firm named after its three founders, Ben Levine, Andrew Manuel and Stefan Renold, whose surname initials spell LMR. All three had been traders at UBS and Goldman Sachs, and Paloma Partners provided seed money before the firm began trading in 2010. Manuel left in 2015 and launched Ixworth Capital, his own global macro hedge fund. The firm focuses on global macro and event-driven strategies, mixing computer-model trading with trades chosen by its portfolio managers.

This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+45.61%
3 Year Est. Return
+238.3%
5 Year Est. Return
+283.63%
10 Year Est. Return
+733.38%
AUM
$32.6B
AUM Growth
+$5.8B
Cap. Flow
-$2.24B
Cap. Flow %
-6.88%
Top 10 Hldgs %
23.21%
Holding
1,999
New
513
Increased
354
Reduced
302
Closed
403
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.6 years

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$215M
2
NVS icon
Novartis
NVS
+$116M
3
LITE icon
Lumentum
LITE
+$91.8M
4
MDT icon
Medtronic
MDT
+$90.8M
5
SHOP icon
Shopify
SHOP
+$88.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.57%
2 Technology 7.25%
3 Healthcare 5.19%
4 Communication Services 3.16%
5 Financials 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TEM icon
576
PUT
Tempus AI
TEM
$11.6B
$6.47M 0.02%
+79,000
New +$4.77M
2026 Q3
0 quarters
MRK icon
577
Merck
MRK
$340B
$6.45M 0.02%
44,422
+392
+0.9% +$54.2K
2025 Q4
3 quarters
CLSK icon
578
CALL
CleanSpark
CLSK
$1.59B
$6.44M 0.02%
+500,000
New +$6.55M
2026 Q3
0 quarters
COGT icon
579
Cogent Biosciences
COGT
$4.84B
$6.44M 0.02%
201,000
+151,000
+302% +$5.58M
2025 Q4
3 quarters
BEAG icon
580
Bold Eagle Acquisition Corp
BEAG
$169M
$6.41M 0.02%
600,000
+100,000
+20% +$1.07M
2025 Q1
6 quarters
VERA icon
581
Vera Therapeutics
VERA
$1.85B
$6.36M 0.02%
196,945
+156,945
+392% +$5.49M
2026 Q1
2 quarters
CRAQ icon
582
Cal Redwood Acquisition Corp
CRAQ
$328M
$6.24M 0.02%
600,000
– –
2025 Q2
5 quarters
MWH icon
583
SOLV Energy
MWH
$5.51B
$6.22M 0.02%
258,790
-257,201
-50% -$7.11M
2026 Q1
2 quarters
CCII icon
584
Cohen Circle Acquisition Corp II
CCII
$6.18M 0.02%
600,000
– –
2025 Q3
4 quarters
XRX icon
585
PUT
Xerox
XRX
$124M
$6.17M 0.02%
1,950,500
+29,600
+2% +$90.3K
2025 Q3
4 quarters
QRED.U icon
586
QuasarEdge Acquisition Corp Units
QRED.U
$6.16M 0.02%
600,000
– –
2026 Q2
1 quarter
GDS icon
587
PUT
GDS Holdings
GDS
$3.14B
$6.14M 0.02%
196,700
– –
2025 Q2
5 quarters
FSLR icon
588
First Solar
FSLR
$16.2B
$6.08M 0.02%
34,726
+33,422
+2,563% +$7.07M
2025 Q1
6 quarters
SVAQ icon
589
Silicon Valley Acquisition Corp
SVAQ
$299M
$6.07M 0.02%
600,000
– –
2026 Q2
1 quarter
KDP icon
590
CALL
Keurig Dr Pepper
KDP
$47.6B
$6.07M 0.02%
200,000
– –
2025 Q3
4 quarters
HWM icon
591
Howmet Aerospace
HWM
$87.9B
$6.04M 0.02%
26,699
+8,066
+43% +$2.12M
2026 Q2
1 quarter
ETHA icon
592
PUT
iShares Ethereum Trust ETF
ETHA
$4.94B
$6.04M 0.02%
100,000
-378,333
-79% -$18.6M
2025 Q3
4 quarters
VRT icon
593
PUT
Vertiv
VRT
$74.9B
$6.03M 0.02%
25,000
– –
2026 Q2
1 quarter
HZO icon
594
MarineMax
HZO
$1.17B
$6.03M 0.02%
+115,318
New +$5.18M
2026 Q3
0 quarters
MTZ icon
595
MasTec
MTZ
$14B
$5.99M 0.02%
28,038
+8,535
+44% +$2.4M
2025 Q3
4 quarters
XP icon
596
CALL
XP
XP
$7.13B
$5.95M 0.02%
+283,200
New +$5.03M
2026 Q3
0 quarters
ONON icon
597
PUT
On Holding
ONON
$10.8B
$5.92M 0.02%
+200,000
New +$6.52M
2026 Q3
0 quarters
CZR icon
598
Caesars Entertainment
CZR
$5.98B
$5.85M 0.02%
197,278
+14,208
+8% +$423K
2026 Q2
1 quarter
LLY icon
599
PUT
Eli Lilly
LLY
$1.23T
$5.79M 0.02%
5,000
-3,100
-38% -$3.66M
2026 Q1
2 quarters
NXT icon
600
Nextpower
NXT
$11.8B
$5.78M 0.02%
74,230
+37,430
+102% +$3.51M
2026 Q1
2 quarters

Similar funds

LMR Partners's Q3 2026 Portfolio in Review

As of Q3 2026, LMR Partners held 1,999 positions worth $32.6B, up 22% from $26.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

LMR Partners withdrew a net $2.24B in Q3 2026, closing 403 positions and reducing 302 holdings. Its most notable exit was Chart Industries, an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, up from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, LMR Partners opened a new position in Lantheus worth $210M.

  • LMR Partners's largest Q3 2026 buy was Lantheus: 2,108,000 shares worth $210M.
  • LMR Partners added most to Novartis in Q3 2026, an estimated $116M increase.
  • LMR Partners's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $632M.
  • LMR Partners fully exited Chart Industries in Q3 2026, selling an estimated $109M.
  • LMR Partners's ten largest holdings make up 23% of its $32.6B portfolio in Q3 2026.
  • LMR Partners opened 513 new positions and closed 403 in Q3 2026.
  • LMR Partners's portfolio value rose 22% quarter-over-quarter to $32.6B.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.